Interplay between circadian and reward pathways in homeostatic response and pathology

昼夜节律和奖励途径在稳态反应和病理学中的相互作用

基本信息

  • 批准号:
    10166690
  • 负责人:
  • 金额:
    $ 34.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-01 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary: Biological processes ranging from gene transcription to behavior oscillate and are synchronized to the 24-hour day/night cycle. Mammalian circadian rhythms, orchestrated by the hypothalamic suprachiasmatic nucleus (SCN) allow appropriately timed physiological and behavioral responses to daily recurring external cues (i.e. sunrise or timed meal availability). The resulting synchrony of physiology to the astronomical day maximizes metabolic efficiency and good health. However, many of the stresses of modern society (i.e. artificial lighting and omnipresence of food) weaken and desynchronize circadian rhythms. This in turn increases the prevalence of many pathologies including metabolic disorders and neurodegenerative diseases. The aim of my laboratory is to determine how circadian rhythms are synchronized to external cues (circadian entrainment) and how desynchronization impacts health. Although the neuronal pathways of light- driven entrainment are well-established, how other external cues, such as food availability, social interactions or exercise, influence the workings of the SCN remains unknown. In a recent breakthrough, we identified a neuronal connection between midbrain dopaminergic neurons that are activated in response to salient events and SCN neurons that express the dopamine receptor Drd1. We showed that this pathway accelerates photoentrainment and drives palatable food consumption outside of mealtimes. In parallel, we identified a novel molecular player that is necessary for anticipation-related activity to time-restricted food access. Here, we propose to leverage our expertise in disentangling circadian entrainment neurocircuitry to delineate the mechanisms by which rewarding cues modulate the SCN circadian clock. Furthermore, we will determine whether strengthening circadian rhythmicity ameliorates symptoms of neurodegenerative diseases. Our first objective is to gain a mechanistic understanding of how salient events impact SCN activity and circadian entrainment. We hypothesize that activation of dopaminergic signaling decreases the amplitude of SCN oscillation and allows faster photoentrainment. This novel insight will be useful to develop strategies to curb the negative impact of circadian desynchrony. Our second goal is to identify the midbrain dopaminergic cell population that targets the SCN and promotes palatable food consumption outside of meal times, leading to weight gain and metabolic disorder. We predict that by mimicking dopaminergic signaling in the SCN, we will control food consumption. Delineating this pathway will provide therapeutic targets against diet induced metabolic dysfunction and obesity. Our final objective is to determine if high amplitude circadian rhythms, by daily consolidation of light and food access, is sufficient to slow the progression of a mouse model of Alzheimer’s disease (AD). If successful, entrainment strategies will become potential treatments for AD patients and people with high-risk of developing AD. We expect our work will provide a better understanding of the relationship between entrainment cues, physiology and behavior while providing tangible strategies against the adverse consequences of circadian misalignment.
项目摘要:从基因转录到行为的生物过程振荡和 与24小时昼夜循环同步。哺乳动物的昼夜节律,由下丘脑协调 视交叉上核(SCN)允许适当的生理和行为反应 反复出现的外部信号(如日出或限时进餐)。由此产生的生理学与 天文日最大限度地提高新陈代谢效率和身体健康。然而,现代社会的许多压力 社会(即人工照明和无处不在的食物)削弱了昼夜节律并使其失去同步性。此入站 TURN增加了包括代谢紊乱和神经退行性变在内的许多病理疾病的患病率 疾病。我的实验室的目的是确定昼夜节律如何与外部线索同步 (昼夜节律夹带)以及去同步化如何影响健康。尽管光的神经通路- 被驱动的夹带是公认的,其他外部线索,如食物供应、社会互动或 运动对中枢神经功能的影响尚不清楚。在最近的一项突破中,我们发现了一种神经元 突显事件后被激活的中脑多巴胺能神经元与SCN的联系 表达多巴胺受体DRD1的神经元。我们发现这一途径加速了光携带。 并在用餐时间之外推动美味的食物消费。与此同时,我们发现了一种新的分子玩家 这对于与预期相关的活动到有时间限制的食物获取是必要的。在这里,我们建议利用 我们在解开昼夜节律缠绕神经回路方面的专业知识,以描绘 奖励的线索调节着SCN的生物钟。此外,我们将确定是否加强 昼夜节律性可以改善神经退行性疾病的症状。我们的第一个目标是获得一个 对显著事件如何影响SCN活动和昼夜节律夹带的机械理解。我们假设 多巴胺能信号的激活降低了SCN振荡的幅度,并允许更快 光夹带作用。这一新的见解将有助于制定遏制昼夜节律负面影响的策略 去同步化。我们的第二个目标是确定针对SCN和SCN的中脑多巴胺能细胞群 在用餐时间以外促进美味的食物消费,导致体重增加和代谢紊乱。我们 预测通过模仿SCN中的多巴胺能信号,我们将控制食物消耗。描绘这一点 PATH将提供针对饮食引起的代谢障碍和肥胖的治疗靶点。我们的决赛 目的是确定通过每日巩固光线和食物通道的高幅度昼夜节律是否 足以减缓阿尔茨海默病(AD)小鼠模型的进展。如果成功,夹带 策略将成为AD患者和AD高危人群的潜在治疗方法。我们 希望我们的工作将提供更好的理解夹带线索,生理学 和行为,同时提供切实的战略,以应对昼夜节律失调的不利后果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ali Guler其他文献

Ali Guler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ali Guler', 18)}}的其他基金

Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
  • 批准号:
    10437612
  • 财政年份:
    2021
  • 资助金额:
    $ 34.46万
  • 项目类别:
Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
  • 批准号:
    10656214
  • 财政年份:
    2021
  • 资助金额:
    $ 34.46万
  • 项目类别:
Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
  • 批准号:
    10793158
  • 财政年份:
    2021
  • 资助金额:
    $ 34.46万
  • 项目类别:
Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
  • 批准号:
    10580516
  • 财政年份:
    2021
  • 资助金额:
    $ 34.46万
  • 项目类别:
Regulation of central circadian rhythms by dopamine
多巴胺调节中央昼夜节律
  • 批准号:
    9338266
  • 财政年份:
    2016
  • 资助金额:
    $ 34.46万
  • 项目类别:
Regulation of central circadian rhythms by dopamine
多巴胺调节中央昼夜节律
  • 批准号:
    10004681
  • 财政年份:
    2016
  • 资助金额:
    $ 34.46万
  • 项目类别:
Regulation of central circadian rhythms by dopamine
多巴胺调节中央昼夜节律
  • 批准号:
    9193742
  • 财政年份:
    2016
  • 资助金额:
    $ 34.46万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 34.46万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 34.46万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 34.46万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 34.46万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 34.46万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 34.46万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 34.46万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 34.46万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 34.46万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 34.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了